Klin Farmakol Farm. 2017;31(2):7-13 | DOI: 10.36290/far.2017.010

Macrolides Drug Interactions in 2017

Michal Prokeš, Ondřej Suchopár, Josef Suchopár
DrugAgency, a. s.

Macrolide antibiotics are popular antibiotic but they cause numerous drug-drug Interactions. Clarithromycin and roxithromycinare inhibitors of CYP3A4. This can harm patients using simvastatin, atoarvastatin, verapamil, diltiazem and other substrates ofCYP3A4. Clarithromycin also inhibits P-glycoprotein, which increase plasma levels of digoxin, trazodon, sildenafil, omeprazol andglibenclamid. Clarithromycin and azithromycin prolong QT interval and can cause arrhythmia torsade de pointes, which can bepotentiated by other drugs with similar action, such as amiodarone, sotalol, haloperidol and others. The close cooperation betweenprescribing physicians, pharmacists and other specialists, (eg. clinical pharmacologist or pharmaceut) is highly recomended toreduce the drug interaction risk for patients.

Keywords: drug-drug interactions, macrolide antibiotics, statins, digoxin, calcium channel blockers, QT interval.

Published: July 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Prokeš M, Suchopár O, Suchopár J. Macrolides Drug Interactions in 2017. Klin Farmakol Farm. 2017;31(2):7-13. doi: 10.36290/far.2017.010.
Download citation

References

  1. SÚKL: http://www.sukl.cz/dodavky-leciv-v-ceske-republice-v-jednotlivych-letech vstup 4.7.2017.
  2. Česká lékařská společnost Jana Evangelisty Purkyně, Subkomise pro antibiotickou politiku (SKAP). Makrolidy. Praktický lékař 2016; 96(4): 166-178. Dostupné na http://www.cls.cz/antibioticka-politika-a.
  3. Kolektiv autorů. Elektronická publikace Databáze lékových interakcí DrugAgency a. s., verze platná k 1.4.2017, www.lekoveinterakce.cz.
  4. Suchopár J. Jsou všechna makrolidová antibiotika stejná z hlediska lékových interakcí? Remedia 2005; 15(4-5): 418-458.
  5. Gorski JC, Jones DR, Haehneer-Daniald BD, et al. The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromy cin. Clin Pharmacol Ther. 1998; 64(2): 133-143. Go to original source... Go to PubMed...
  6. Yeates RA, Laufen H, Zimmermann T, Schumacher T. Pharmacokinetic and pharmacodynamic interaction study between midazolam and the macrolide antibiotics, erythromycin, clarithromycin, and the azalide azithromycin. Int J Clin Pharmacol Ther. 1997; 35(12): 577-579.
  7. Quinney SK, Haehner BD, Shroades MB, et al. Interaction between midazolam and clarithromycin in the elderly. Br J Clin Pharmacol 2008; 65: 98-109. Go to original source... Go to PubMed...
  8. Quinney SK, Mailireddy SR, Vuppalanchi R, et al. Rate of onset of inhibition of gut-wall and hepatic CYP3A by clarithromycin. Eur J Clin Pharmacol 2013; 69(3): 439-448. Go to original source... Go to PubMed...
  9. SPC přípravku Zocor (simvastatin); Merck Sharp & Dohme B.V., 2015 http://www.sukl.cz/modules/medication/search.php, vstup 5.5.2017.
  10. Jacobson TA. Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors. Am J Cardiol. 2004; 94(9): 1140-1146. Go to original source... Go to PubMed...
  11. SPC přípravku Sortis (atorvastatin); Pfizer, 2016 http://www.sukl.cz/modules/medication/search.php, vstup 5.5.2017.
  12. Patel AM, et al. Statin toxicity from macrolide antibiotic coprescription: a population-based cohort study. Ann Intern Med 2013; 158: 860-876. Go to original source... Go to PubMed...
  13. Li DQ, Kim R, McArthur E, et al. Risk of adverse events among older adults following co-prescription of clarithromycin and statins not metabolized by cytochrome P450 3A4. CMAJ. 2015; 187(3): 174-180. doi: 10.1503/cmaj.140950. Epub 2014 Dec 22. Go to original source... Go to PubMed...
  14. SPC přípravku Crestor (rosuvastatin); AstraZeneca, 2017, http://www.sukl.cz/modules/medication/search.php vstup 20.5.2017.
  15. Strandel J, Bate A, Hägg S, Edwards IR. Rhabdomyolysis a result of azithromycin and statins: an unrecognized interaction. Br J Clin Pharmacol. 2009; 68(3): 427-434. Go to original source... Go to PubMed...
  16. Bucher M, Mair G, Kees F. Effect of roxithromycin on the pharmacokinetics of lovastatin in volunteers. Eur J Clin Pharmacol 2002; 57: 787-791. Go to original source... Go to PubMed...
  17. Wright AJ, Gomes T, Mamdani MM, Horn JR, Juurlink DN. The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockers. CMAJ. 2011; 183(3): 303-307. Go to original source... Go to PubMed...
  18. Gandhi S, Fleet JL, Bailey DG. Calcium-channel blocker-clarithromycin drug interactions and acute kidney injury. JAMA. 2013; 310(23): 2544-2553. Go to original source... Go to PubMed...
  19. Agrawal V, Chaudhari S, Sy A, et al. A case of hypotension and bradycardia precipitated by drug interaction of clarithromycin and chalcium-channel blocker. J Am Geriatr Soc 2015; 63: 1966-1967. Go to original source... Go to PubMed...
  20. Takeuchi S, Kotani Y, Tsujimoto T. Hypotension induced by the concomitant use of calcium-channel blocker and clarithromycin. BMJ Case Rep 2017; Jan 9; 2017. pii: bcr2016218388. doi: 10.1136/bcr-2016-218388. Go to original source... Go to PubMed...
  21. SPC přípravku Klacid 250, 500 mg (klarithromycin); Abbott Laboratories, 2017 http://www.sukl.cz/modules/medication/search.php, vstup 5.5.2017.
  22. Zapater P, Reus S, Tello A, et al. A prospective study of the clarithromycin-digoxin interaction in elderly patients. J Antimicrob Chemother 2002; 50: 601-606. Go to original source... Go to PubMed...
  23. Farkas D, Volak LP, Harmatz JS, et al. Short-term clarithromycin administration impairs clearance and enhances pharmacodynamic effects of trazodone but not of zolpidem. Clin Pharmacol Ther. 2009; 85(6): 644-650. Go to original source... Go to PubMed...
  24. Hedaya MA, El-Afify DR, El-Maghraby GM. The effect of ciprofloxacin and clarithromycin on sildenafil oral bioavailability in human volunteers. Biopharm Drug Dispos. 2006; 27(2): 103-110. Go to original source... Go to PubMed...
  25. Furuta T, Ohashi K, Kobavashi K, et al. Effects of clarithromycin on the metabolism of omeprazole in relation to CYP2C19 genotype status in humans. Clin Pharmacol Ther. 1999; 66(3): 265-274. Go to original source... Go to PubMed...
  26. Lilja JJ, Niemi M, Fredrikson H, Neuvonen PJ. Effects of clarithromycin and grapefruit juice on the pharmacokinetics of glibenclamide. Br J Clin Pharmacol 2007; 63: 732-740. Go to original source... Go to PubMed...
  27. Schelleman H, Bilker WB, Brensinger CM, et al. Anti-infectives and the risk of severe hypoglycemia in users of glipizide or glyburide. Clin Pharmacol Ther. 2010; 88(2): 214-222. Go to original source... Go to PubMed...
  28. Juurlink DN, Mamdani M, Kopp A, et al. Drug-drug interaction among elderly patients hospitalized for drug toxicity. JAMA 2003; 289: 1652-1658. Go to original source... Go to PubMed...
  29. Nordt SP, Williams SR, Manoguerra AS, Clark RF. Clarithromycin induced digoxin toxicity. J Accid Emerg Med 1998; 15(3): 194-195. Go to original source... Go to PubMed...
  30. Midoneck SR, Etingin OR. Clarithromycin-related toxic effects of digoxin. N Engl J Med 1995; 333(22): 1505. Go to original source... Go to PubMed...
  31. Lee CY, Marcotte F, Giraldeou G, et al. Digoxin toxicity precipitated by clarithromycin use: case presentation and concise review of the literature. Can J Cardiol. 2011; 27(6): 870.e15-6. Go to original source... Go to PubMed...
  32. Corallo CE, Rogers IR. Roxithromycin-induced digoxin toxicity. Med J Aust 1996; 165: 433-444. Go to original source... Go to PubMed...
  33. Ten Eick AP, Sallee D, Preminger T, et al. Possible drug interaction between digoxin and azithromycin in a young child. Clin Drug invest 2000; 20: 61-64. Go to original source...
  34. Hughes J, Crowe A. Inhibition of P-glycoprotein-mediated efflux of digoxin and its metabolites by macrolide antibiotics. J Pharmacol Sci. 2010; 113(4): 315-324. Go to original source... Go to PubMed...
  35. Kolektiv: Stockley's Drug Interaction, 9. vydání, 2010: str. 417-420. Go to original source...
  36. SPC Pradaxa (dabigatran), Boehringer-Ingelheim, http://www.sukl.cz/modules/medication/search.php, vstup duben 2017.
  37. Delavenne X, et al. A semi-mechanistic absorption model to evaluate drug-drug interaction with dabigatran: application with clarithromycin. Br J Clin Pharmacol 2013; 76: 107-113. Go to original source... Go to PubMed...
  38. SPC Xarelto (rivaroxaban), Bayer Pharma, http://www.sukl.cz/modules/medication/search.php, vstup duben 2017.
  39. SPC Eliquis (apixaban), Bristol-Myers Squibb/Abbott, http://www.sukl.cz/modules/medication/search.php, vstup duben 2017.
  40. SPC Lixiana (edoxaban), Daiichi Sankyo Europe, http://www.sukl.cz/modules/medication/search.php, vstup duben 2017.
  41. Praktická doporučení European Heart Rhythm Associtation pro použití nových perorálních antikoagulancií u pacientů s nevalvulární fibrilací síní. Souhrnný dokument připravený Českou kardiologickou společností Robert Čihák, Luděk Haman, Miloš Táborský. www.kardio-cz.cz, Cor et Vasa 2016; 58: e153-e174.
  42. Brion N, Kollenbach K, Marion MH, et al. Effect of a macrolide (spiramycin) on the pharmacokineetics of L-dopa and carbidopad in healthy volunteers. Clin neuropharmacol 1992; 15: 229-235. Go to original source... Go to PubMed...
  43. Woosley, RL and Romero, KA, www.Crediblemeds.org, QTdrugs List, [vstup 5.5.2016], AZCERT, Inc. 1822 Innovation Park Dr., Oro Valley, AZ 85755.
  44. SPC přípravku Sumamed (azithromycin), Teva 2015 (http://www.sukl.cz/modules/medication/search.php).
  45. Horton R, Barber C. Opioid-induced respirátory depression resulting from transdermal fentanyl-clarithromycin drug interaction in a patient with advanced COPD. J Pain Symptom Manage 2009; 37(6): e2-e5. Go to original source... Go to PubMed...
  46. Cronnolly B, Pergrum H. Fentanyl-clarithromycin interaction. BMJ Case Rep 2012; Jul 9; 2012. pii: bcr0220125936. doi: 10.1136/bcr.02.2012.5936. Go to original source... Go to PubMed...
  47. Kovács G, Péter L. Complex hallucination (visual-auditory) during coadministration of tramadol and clarithromycin. Neuropsychopharmacol Hung. 2010; 12(1): 309-312. Go to PubMed...




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.